Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BIONTECH SE

(BNTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Sector news Bio Therapeutic Drugs
01/20ANALYST RECOMMENDATIONS : Activision Blizzard, AMD, Bumble, Etsy, Ford...
01/20BMO Capital Lifts Vertex Pharmaceuticals to Outperform From Market Perform, Price Targe..
MT
01/19SiteOne Therapeutics Announces Collaboration and License Agreement with Vertex Pharmace..
CI
01/19Regeneron Says US FDA Accepts for Review its Supplemental BLA for Libtayo in Combinatio..
MT
01/19Regeneron Says FDA to Review Libtayo/Chemotherapy Combo in First-Line NSCLC Treatment
DJ
01/19FDA Accepts for Review Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy for ..
CI
01/19ANALYST RECOMMENDATIONS : Activision Blizzard, Chevron, Exxon Mobil, Gilead, Goldman Sachs..
01/19Sanofi, Regeneron Say Dupixent Significantly Reduces Itching in Prurigo Nodularis Patie..
MT
01/19Sanofi-Regeneron's Dermatitis Drug Lowers Itch, Skin Lesions In Late-Stage Trial
MT
01/18Gilead says counterfeit HIV drugs ended up with patients
RE
01/18Morgan Stanley Lowers Price Target for Gilead Sciences to $72 From $74, Maintains Equal..
MT
01/18Gilead says counterfeiting network sold $250 mln worth of its HIV drugs
RE
01/18Morgan Stanley Adjusts Regeneron Pharmaceuticals Price Target to $585 From $617, Mainta..
MT
01/18WuXi AppTec Co., Ltd. Provides Earnings Guidance for the Year Ended December 31, 2021
CI
01/14Gilead withdraws use of Zydelig to treat two types of cancer
RE
01/14Gilead withdraws use of Zydelig to treat two types of cancer
RE
01/13WHO recommends Eli Lilly, GSK-Vir's drugs, widening COVID-19 treatment pool
RE
01/13Countryside Slumps 17% as CEO Steps Down Amid Deal with Activist Investor
MT
01/13Countryside Properties CEO Steps Down; Chair Named As Interim Successor
MT
01/11Vertex's Cystic Fibrosis Combo Gets Extended EU Nod For Treating Children
MT
01/11Vertex Secures European Commission's Approval for Kaftrio With Ivacaftor as Treatment f..
MT
01/11Vertex Pharmaceuticals Incorporated announces European Commission Approves KAFTRIO® (iv..
CI
01/10Gilead, Merck & Co. to Evaluate Lung Cancer Combo Therapy in Two Clinical Studies
MT
01/10Gilead Sciences, Merck To Study Trodelvy, Keytruda Combination For Treatment of Lung Ca..
MT
01/10Gilead Announces Clinical Trial Collaborations With Merck to Evaluate Trodelvy® in Comb..
CI
01/10Regeneron's Covid-19 Antibody Cocktail Had 2021 U.S. Sales Near $6 Billion
DJ
01/07Regeneron Pharmaceuticals, Ultragenyx Pharmaceutical Strike Commercialization Deal for ..
MT
01/07Regeneron, Ultragenyx Ink International Deal on Cholesterol Drug Evkeeza
DJ
01/07Regeneron Pharmaceuticals, Inc. and Ultragenyx Pharmaceutical Inc. Announce a License a..
CI
01/06Gilead Sciences, Inc. Announces Retirement of Brett A. Pletcher as Executive Vice Presi..
CI
01/06Morgan Stanley Downgrades Gilead Sciences to Equalweight From Overweight, Cuts Price Ta..
MT
01/06RBC Raises Price Target on Vertex Pharmaceuticals to $268 From $265, Maintains Outperfo..
MT
01/06RBC Lifts Price Target on Gilead Sciences to $87 From $86, Maintains Outperform Rating
MT
01/06ANALYST RECOMMENDATIONS : Bank of America, Dollar General, Evercore, Reckitt Benckiser, Un..
01/05BofA Securities Downgrades Regeneron Pharmaceuticals to Underperform From Neutral
MT
01/03Bernstein Upgrades Regeneron Pharmaceuticals to Outperform From Market Perform; Price T..
MT
2021Wuxi Apptec Co., Ltd. Announces Promotion of Shi Ming as Chief Financial Officer with E..
CI
2021COVID-19 Vaccine Names May Face 'Volatile' 2022, Oppenheimer Says
MT
2021-Russia extends production of COVID-19 drug remdesivir without patent for a year
RE
2021Russia extends production of COVID-19 drug remdesivir without patent for a year
RE
2021Diversified Healthcare Trust's Sale of 35% Stake in Boston Properties Lifts Liquidity A..
MT
2021Diversified Healthcare Trust to Sell 35% Stake in Joint Venture for $378 Million
MT
2021NRX Pharmaceuticals Seeks FDA's Breakthrough Therapy Status For COVID-19 Therapy Zyesam..
MT
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on BIONTECH SE